Can Lowering Homocysteine Levels Reduce Cardiovascular Risk?
- 2 February 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (5) , 328-329
- https://doi.org/10.1056/nejm199502023320511
Abstract
High serum cholesterol levels are an important risk factor for coronary disease, but most patients with myocardial infarction have normal cholesterol levels. Despite considerable advances in our understanding of the causes of cardiovascular disease, the established risk factors cannot fully explain its occurrence. The article by Selhub and colleagues1 in this issue of the Journal contributes importantly to the rapidly accumulating evidence that elevated blood levels of homocysteine increase the risk of vascular disease.The original hypothesis, proposed by McCully,2 was based on postmortem findings of arteriosclerotic disease in patients with extraordinarily high blood homocysteine levels due to rare metabolic . . .Keywords
This publication has 7 references indexed in Scilit:
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.Proceedings of the National Academy of Sciences, 1994
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Vitamin status and intake as primary determinants of homocysteinemia in an elderly populationJAMA, 1993
- Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.Circulation, 1993
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physiciansPublished by American Medical Association (AMA) ,1992